BlackRock Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$4.21M Buy
104,738
+33,500
+47% +$1.35M ﹤0.01% 1275
2016
Q3
$2.58M Buy
71,238
+4,264
+6% +$154K ﹤0.01% 1444
2016
Q2
$1.94M Buy
66,974
+4,829
+8% +$140K ﹤0.01% 1560
2016
Q1
$2.17M Buy
62,145
+4,920
+9% +$172K ﹤0.01% 1485
2015
Q4
$1.85M Buy
57,225
+855
+2% +$27.6K ﹤0.01% 1524
2015
Q3
$1.82M Buy
56,370
+343
+0.6% +$11.1K ﹤0.01% 1539
2015
Q2
$2.32M Sell
56,027
-247
-0.4% -$10.2K ﹤0.01% 1466
2015
Q1
$2.53M Sell
56,274
-4,503
-7% -$202K ﹤0.01% 1372
2014
Q4
$2.28M Buy
60,777
+10,872
+22% +$407K ﹤0.01% 1413
2014
Q3
$1.74M Sell
49,905
-6,538
-12% -$228K ﹤0.01% 1468
2014
Q2
$1.99M Sell
56,443
-13,971
-20% -$493K ﹤0.01% 1444
2014
Q1
$2.3M Sell
70,414
-702
-1% -$22.9K ﹤0.01% 1460
2013
Q4
$3M Buy
71,116
+6,336
+10% +$267K ﹤0.01% 1261
2013
Q3
$2.58M Buy
64,780
+10,290
+19% +$410K ﹤0.01% 1323
2013
Q2
$2.25M Buy
+54,490
New +$2.25M ﹤0.01% 1229